Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
19 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Clopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover)“
Suchtreffer
Begriffe & Kennungen
Clopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.5 · Varicella vaccine It is recommended that patients not be given salicylates for an interval of six weeks after
Eintrag öffnenClopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenClopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.8 Undesirable effects · 1
Eintrag öffnenClopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.8 · 10 System organ Common Uncommon Rare Very rare, not known class Blood and the Thrombocytopenia, Neutropenia, T
Eintrag öffnenClopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.8 · 11 System organ Common Uncommon Rare Very rare, not known class Nervous system Intracranial Taste disturbances
Eintrag öffnenClopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.8 · 12 System organ Common Uncommon Rare Very rare, not known class Gastrointestinal Gastrointestinal Gastric ulce
Eintrag öffnenClopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.8 · 13 System organ Common Uncommon Rare Very rare, not known class Hepatobiliary Acute liver failure, disorders l
Eintrag öffnenClopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.8 · 14 * Information reported in published information for ASA with frequency “not known”. ** Information related
Eintrag öffnenClopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.8 · Adverse reactions that occurred with clopidogrel alone, with ASA alone or with clopidogrel in combination with
Eintrag öffnenClopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.8 · Bleeding is the most common reaction reported both in clinical studies as well as in the post-marketing experi
Eintrag öffnenClopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.8 · Clopidogrel has been evaluated for safety in more than 42,000 patients who have participated in clinical studi
Eintrag öffnenClopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.8 · Eye disorders Eye bleeding (conjunctival, ocular, retinal) Ear and labyrinth Vertigo Hearing loss* or disorder
Eintrag öffnenClopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.8 · In CAPRIE, in patients treated with either clopidogrel or ASA, the overall incidence of any bleeding was 9.3%.
Eintrag öffnenClopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.8 · In CLARITY, there was an overall increase in bleeding in the clopidogrel plus ASA group vs. the group taking A
Eintrag öffnenClopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.8 · In COMMIT, the overall rate of noncerebral major bleeding or cerebral bleeding was low and similar in both gro
Eintrag öffnenClopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.8 · In CURE there was no excess in major bleeds with clopidogrel plus ASA within 7 days after coronary bypass graf
Eintrag öffnenClopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenClopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.8 · Summary of the safety profile
Eintrag öffnenClopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.8 · Tabulated list of adverse reactions
Eintrag öffnen